84 filings
8-K
ADMS
Adamas Pharmaceuticals Inc
24 Nov 21
Completion of Acquisition or Disposition of Assets
9:18am
8-K
ADMS
Adamas Pharmaceuticals Inc
12 Oct 21
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
6:59am
8-K
ADMS
Adamas Pharmaceuticals Inc
9 Aug 21
Adamas reports second quarter 2021 financial results
4:04pm
8-K
ADMS
Adamas Pharmaceuticals Inc
11 Jun 21
Departure of Directors or Certain Officers
4:00pm
8-K
ADMS
Adamas Pharmaceuticals Inc
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
82c2qlr kt4
10 May 21
Adamas reports first quarter 2021 financial results
4:04pm
8-K
51yf6u7z4
25 Feb 21
Other Events
4:15pm
8-K
rsc6zxy6
23 Feb 21
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
bspn 6x4jt5oghaokhb3
1 Feb 21
Entry into a Material Definitive Agreement
8:05am
8-K
we5s8r
13 Jan 21
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
9:27am
8-K
m86myq pduygbhxyj16
2 Dec 20
Entry into a Material Definitive Agreement
6:59am
8-K
zzlqenfvt9cwb5
23 Nov 20
Departure of Directors or Certain Officers
9:20am
8-K
no0 gthexkk
5 Nov 20
Adamas Reports Third Quarter 2020 Financial Results
4:08pm
8-K
pbquxel2cj fvhl60mv
1 Sep 20
Departure of Directors or Certain Officers
9:19am
8-K
7abw8zfi5 1bon
6 Aug 20
Adamas Reports Second Quarter 2020 Financial Results
4:04pm
8-K
hy19 93v6df0kzw6ow1f
17 Jun 20
Other Events
4:03pm
8-K
tbftg229fmqbbipvetv
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
5va micnw
4 Jun 20
Other Events
4:32pm
8-K
s7oo87d3pi2kqwk0r
7 May 20
Adamas Reports First Quarter 2020 Financial Results
4:07pm
8-K
b0xorcp9 xso3pim33xf
25 Feb 20
Adamas Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm